Clinical Observation on Chronic Severe Hepatitis at Early-Middle Stage Treated with Retention Enema of JieDu ZhuYuFang

YE Pei-yan,MIAO Hui,YANG Zong-guo,CHEN Xiao-rong,LU Yun-fei,LIU Cheng
DOI: https://doi.org/10.3969/j.issn.1004-6852.2012.07.001
2012-01-01
Abstract:Objective: To observe clinical effects of JieDu ZhuYuFang in treating chronic severe hepatitis at early and middle stage.Method: A total of 79 patients were divided into 31 cases in enema group and 48 cases in control group according to receiving enema or not.Control group received routine western medicine;enema group received routine western medicine and retention enema with 100 ml of JieDu ZhuYuFang,once per day.Liver function,blood coagulation function,complication and survival rates of patients were observed.Result: ALT,AST,TBiL and DBiL of patients in enema group decreased,content of total cholesterol increased(P0.05);compared with control group,enema group improved more greatly in ALT,AST,DBiL and TC(P0.05).Time of prothrombin shortened notably in enema group and the activity improved(P0.05);enema group improved significantly compared with compared with control group(P0.05).Complications of patients in enema group decreased,survival rate improved,comparison with control group showed statistical meaning(P0.05).Conclusion: JieDu ZhuYuFang can effectively improve liver function and coagulation of patients with chronic severe hepatitis at early and middle stage with better clinical effects,decrease complication and raise survival rate.
What problem does this paper attempt to address?